PAI Pharma
Leading manufacturer of high-quality generic liquid pharmaceuticals for nearly 50 years, ensuring health and safety.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
* | N/A | Buyout | |
| Total Funding | 000k | ||
PAI Pharmaceutical Associates, Inc. specializes in the production of generic liquid pharmaceuticals, serving both prescription (Rx) and over-the-counter (OTC) markets. Established in 1969, the company has a long-standing commitment to quality and safety in its product offerings. PAI's client base includes healthcare providers, pharmacies, and distributors who require reliable and cost-effective medication solutions. Operating primarily in the pharmaceutical industry, PAI focuses on producing high-quality liquid medications that meet stringent regulatory standards. The business model revolves around manufacturing and distributing these generic pharmaceuticals, generating revenue through sales to various healthcare entities. PAI's dedication to quality ensures that their products are trusted by professionals and patients alike.
Keywords: generic pharmaceuticals, liquid medications, Rx products, OTC products, healthcare providers, pharmacies, distributors, quality assurance, regulatory compliance, cost-effective solutions.